Site-Overview.com
 

Websites using embolization as a keyword

Here you can see a list of websites which are using embolization as keyword according to our database.

 
Websites found: 12
Number of websited displayed: 12
 

List of results:

F. Edward Boas -- Home page
http://site-overview.com/stats/edboas.com
  • Website Address renewal date: 13/6/14
  • Domain Address Reg. date: 13/6/14
  • Website address in use until: 18/6/14
Activase® (Alteplase) for Acute Ischemic Stroke Treatment
http://site-overview.com/stats/activase.com
Learn more about Activase® (Alteplase) for Acute Ischemic Stroke Treatment. Indications Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon as possible but within 3 hours after symptom onset. Activase is indicated for use in acute myocardial infarction (AMI) for the reduction of mortality and reduction of the incidence of heart failure. Limitation of Use: The risk of stroke may outweigh the benefit produced by thrombolytic therapy in patients whose AMI puts them at low risk for death or heart failure. Activase is indicated for the lysis of acute massive pulmonary embolism (PE), defined as: • Acute pulmonary emboli obstructing blood flow to a lobe or multiple lung segments. • Acute pulmonary emboli accompanied by unstable hemodynamics, e.g.,failure to maintain blood pressure without supportive measures. Important Safety Information Contraindications Do not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit: current intracranial hemorrhage (ICH); subarachnoid hemorrhage; active internal bleeding; recent (within 3months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding; bleeding diathesis; and current severe uncontrolled hypertension. Do not administer Activase to treat acute myocardial infarction or pulmonary embolism in the following situations in which the risk of bleeding is greater than the potential benefit: active internal bleeding; history of recent stroke; recent (within 3months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding; bleeding diathesis; and current severe uncontrolled hypertension. Warnings and Precautions Bleeding Activase can cause significant, sometimes fatal, internal or external bleeding, especially at arterial and venous puncture sites.Avoid intramuscular injections and trauma to the patient. Fatal cases of hemorrhage associated with traumatic intubation in patients administered Activase have been reported. Heparin, aspirin, or Activase may cause bleeding complications; therefore carefully monitor for bleeding. If serious bleeding occurs, terminate the Activase infusion. Orolingual Angioedema Monitor patients during and for several hours after infusion for orolingual angioedema. If angioedema develops, discontinue the Activase infusion and promptly institute appropriate therapy. Cholesterol Embolization Cholesterol embolism, sometimes fatal, has been reported rarely in patients treated with thrombolytic agents. Reembolization of Deep Venous Thrombi during Treatment for Acute Massive Pulmonary Embolism Consider the possible risk of reembolization due to the lysis of underlying deep venous thrombi patients with acute massive PE Coagulation Tests May be Unreliable during Activase Therapy Coagulation tests and/or measures of fibrinolytic activity may be unreliable during Activase therapy. Adverse Reactions The most frequent adverse reaction associated with Activase therapy is bleeding. Allergic‑type reactions, e.g.,anaphylactoid reaction, laryngeal edema, orolingual angioedema, rash, and urticaria have been reported.
  • Google Analytics ID: 291924-57
  • Website Address renewal date: 16/10/19
  • Domain Address Reg. date: 99/4/23
  • Website address in use until: 18/4/23
Эмболизация маточных артерий (ЭМА)
http://site-overview.com/stats/embolization.ru
Самая полная информация о методе эмболизация маточных артерий в лечении миомы матки на сайте embolization.ru
  • Google+ Identity: 112982189579158712219
  • Google Analytics ID: 34754280-1
  • Website Address renewal date: 17/8/5
  • Domain Address Reg. date: 11/4/28
  • Website address in use until: 18/4/28
Uterine Fibroids Treatment with Embolization (UFE)
http://site-overview.com/stats/fibroids.com
The Fibroid Treatment Collective is dedicated to curing Fibroids with minimally invasive therapy, Uterine Fibroid Embolization (UFE) avoiding major surgery.
  • Google+ Identity: +Fibroidstreatmentcollective
  • Google Analytics ID: 8928418-1
  • Website Address renewal date: 17/3/3
  • Domain Address Reg. date: 97/9/22
  • Website address in use until: 17/9/21
QSight - Web-Based Healthcare Inventory Management
http://site-overview.com/stats/qsight.net
QSight is the totally Web-based system that simplifies inventory management and saves time and money for clinical departments such as IR, cath labs, EP and the OR. Call 877-QSIGHT8 for the complete story.
  • Website Address renewal date: 15/8/27
  • Domain Address Reg. date: 04/9/7
  • Website address in use until: 19/9/7
Interventional Urology | Fusion Biopsy & Prostate MRI
http://site-overview.com/stats/interventionalurology.com
Fusion Biopsy, UroNAv, Prostate Cancer, Elevated PSA, Varicocele Embolization
  • Google Analytics ID: 40919465-1
  • Website Address renewal date: 17/6/11
  • Domain Address Reg. date: 12/6/11
  • Website address in use until: 19/6/11
Global Embolization Symposium and Technologies - GEST 2015
http://site-overview.com/stats/gestweb.org
  • Website Address renewal date: 16/6/9
  • Domain Address Reg. date: 08/6/8
  • Website address in use until: 17/6/8
王彥博的基地營
http://site-overview.com/stats/embolization.blogspot.com
王彥博醫師的部落格;宸宸寶的爸比;自助旅行者;各種運動愛好;整形外科專科醫師.
  • Google+ Identity: 116564245008331115905
  • Google Adsense Publisher: pub-1556223355139109
Leading No-Surgery Fibroids Doctor - Atlanta UFE Specialist • John C. Lipman, MD, FSIR specializes in Uterine Fibroid Embolization. With over 6,000 procedures, he is recognized as a global UFE leader and a "Top Doc."
http://site-overview.com/stats/atlii.com
John C. Lipman, MD, FSIR specializes in Uterine Fibroid Embolization. With over 6,000 procedures, he is recognized as a global UFE leader and a "Top Doc."
  • Google Analytics ID: 67566508-1
  • Website Address renewal date: 17/8/9
  • Domain Address Reg. date: 04/8/16
  • Website address in use until: 20/6/21
New Haven Interventional Radiologist Raj Ayyagari
http://site-overview.com/stats/rajayyagarimd.com
Learn more about minimally-invasive treatments performed by New Haven interventional radiologist Raj Ayyagari. Dr. Ayyagari safely treats BPH, fibroids, varicoceles, and more!
  • Google Analytics ID: 100576002-1
  • Website Address renewal date: 18/1/4
  • Domain Address Reg. date: 16/1/19
  • Website address in use until: 19/1/19
Uterine Fibroid Embolization Treatment Centers - USA
http://site-overview.com/stats/usafibroidcenters.com
USA Fibroid Centers offers non-surgical treatment for uterine fibroids called Uterine Fibroid Embolization. Schedule a consultation with us.
  • Google+ Identity: 112909525381391934865
  • Google Analytics ID: 91355744-1
  • Website Address renewal date: 17/8/4
  • Domain Address Reg. date: 16/8/3
  • Website address in use until: 18/8/3
Leading No-Surgery Fibroids Doctor - Atlanta UFE Specialist • John C. Lipman, MD, FSIR specializes in Uterine Fibroid Embolization. With over 6,000 procedures, he is recognized as a global UFE leader and a "Top Doc."
http://site-overview.com/stats/atlantafibroidcenter.com
John C. Lipman, MD, FSIR specializes in Uterine Fibroid Embolization. With over 6,000 procedures, he is recognized as a global UFE leader and a "Top Doc."
  • Google Analytics ID: 67566508-1
  • Website Address renewal date: 17/3/20
  • Domain Address Reg. date: 15/3/19
  • Website address in use until: 18/3/19
2024-05-28 19:47:50 ... 0.0147